Novartis AG is 1.4x more valuable than Novo Nordisk A/S by market capitalization ($283.13 B vs $202.94 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NVO | NVS |
|---|---|---|
| Market cap | $202.94 B | $283.13 B |
| US-listed rank | #67 | #47 |
| SEC filings | 998 | 947 |
Novartis AG is 1.4x more valuable than Novo Nordisk A/S by market capitalization ($283.13 B vs $202.94 B).
Full pages: Novo Nordisk A/S and Novartis AG, or browse the full rankings.